Table 3.
N | Mean Adherence | Standard Deviation | Range | |
---|---|---|---|---|
Overall Adherence Baseline | 57 | 93.65 | 12.02 | 40–100 |
Overall Adherence 12-weeks | 53 | 93.59 | 12.17 | 40–100 |
Overall Adherence 24-weeks | 48 | 95.85 | 6.92 | 68.5–100 |
Psychotropic Baseline | 24 | 91.42 | 14.60 | 40–100 |
Psychotropic 12-weeks | 22 | 92.73 | 15.18 | 50–100 |
Psychotropic 24-weeks | 20 | 91.50 | 16.31 | 50–100 |
ARV Baseline | 26 | 95.91 | 10.16 | 50–100 |
ARV 12-weeks | 24 | 92.28 | 15.58 | 40–100 |
ARV 24-weeks | 25 | 96.61 | 6.43 | 80–100 |
Other Baseline | 45 | 94.25 | 11.55 | 40–100 |
Other 12-weeks | 40 | 96.35 | 8.47 | 60–100 |
Other 24-weeks | 35 | 96.78 | 8.50 | 65–100 |
PEG-INF Adherence 12-weeks | 47 | 97.87 | 7.05 | 75–100 |
PEG-INF Adherence 24-weeks | 31 | 98.39 | 8.98 | 50–100 |
RBV Adherence 12-weeks | 47 | 96.70 | 7.42 | 70–100 |
RBV Adherence 24-weeks | 31 | 97.26 | 7.73 | 60–100 |
Note. ARV = antiretroviral; PEG-INF = pegylated interferon; RBV = ribavirin.